Amazon cover image
Image from Amazon.com

Public health effectiveness of the FDA 510(k) clearance process : measuring postmarket performance and other select topics : workshop report / Theresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.

Contributor(s): Material type: TextTextPublication details: Washington, D.C. : National Academies Press, ©2011.Description: 1 online resource (xiv, 118 pages) : illustrations (chiefly color)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780309162074
  • 0309162076
  • 1283134977
  • 9781283134972
  • 9780309215114
  • 0309215110
Other title:
  • FDA 510(k) clearance process [Running title]
Subject(s): Genre/Form: Additional physical formats: Print version:: Public health effectiveness of FDA 510(k) clearance process.DDC classification:
  • 362.10685
LOC classification:
  • RA399.A3 P82 2011eb
NLM classification:
  • 2011 H-653
  • W 26
Online resources:
Contents:
Introduction -- Food and Drug Administration Postmarket Surveillance Activities and Recall Studies of Medical Devices -- Non-Food and Drug Administration Sources of Adverse Event Data -- Postmarket Surveillance of Medical Devices: Panel Discussion -- Other Select Topics -- Appendix A: Workshop Agenda -- Appendix B: Biographic Information on Invited Speakers, Panelists, and Authors of Commissioned Papers -- Appendix C: 510(k) Premarket Notification Analysis of FDA Recall Data -- Appendix D: Trustworthy Medical Device Software.
Summary: "The Food and Drug Administration (FDA) is responsible for ensuring that medical devices are safe and effective before they go on the market. Section 510(k) of the Federal Food, Drug, and Cosmetic Act requires a manufacturer of medical devices to notify FDA of its intent to market a medical device at least 90 days in advance. That window of time allows FDA to evaluate whether the device is substantially equivalent to a product already legally on the market (called a predicate), in which case the device does not need to go through the premarket approval (PMA) process. As part of its assessment of the FDA's premarket clearance process for medical devices, the Institute of Medicine (IOM) held a workshop on July 28, 2010 to discuss how medical devices are monitored for safety after they are available to consumers. Its primary focus was on monitoring the safety of marketed medical devices, including FDA's postmarket surveillance activities, analysis of safety concerns that resulted in medical device recalls, and non-FDA sources of adverse-event information. Public Health Effectiveness of the FDA 501(K) Clearance Process summarizes the views of the workshop participants."--Publisher's description
Item type:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Collection Call number Materials specified Status Date due Barcode
Electronic-Books Electronic-Books OPJGU Sonepat- Campus E-Books EBSCO Available

Includes bibliographical references.

Introduction -- Food and Drug Administration Postmarket Surveillance Activities and Recall Studies of Medical Devices -- Non-Food and Drug Administration Sources of Adverse Event Data -- Postmarket Surveillance of Medical Devices: Panel Discussion -- Other Select Topics -- Appendix A: Workshop Agenda -- Appendix B: Biographic Information on Invited Speakers, Panelists, and Authors of Commissioned Papers -- Appendix C: 510(k) Premarket Notification Analysis of FDA Recall Data -- Appendix D: Trustworthy Medical Device Software.

"The Food and Drug Administration (FDA) is responsible for ensuring that medical devices are safe and effective before they go on the market. Section 510(k) of the Federal Food, Drug, and Cosmetic Act requires a manufacturer of medical devices to notify FDA of its intent to market a medical device at least 90 days in advance. That window of time allows FDA to evaluate whether the device is substantially equivalent to a product already legally on the market (called a predicate), in which case the device does not need to go through the premarket approval (PMA) process. As part of its assessment of the FDA's premarket clearance process for medical devices, the Institute of Medicine (IOM) held a workshop on July 28, 2010 to discuss how medical devices are monitored for safety after they are available to consumers. Its primary focus was on monitoring the safety of marketed medical devices, including FDA's postmarket surveillance activities, analysis of safety concerns that resulted in medical device recalls, and non-FDA sources of adverse-event information. Public Health Effectiveness of the FDA 501(K) Clearance Process summarizes the views of the workshop participants."--Publisher's description

Print version record.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide

There are no comments on this title.

to post a comment.

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library